Fact CheckerSign in

NCT05089864Completed

STAR and Deferred Stenting Study

Outcomes and Safety in Patients Treated With STAR and Deferred Stenting After Unsuccessful CTO PCI

Source: ClinicalTrials.gov · Last updated 24 Oct 2025

Brief summary (registry, in English)

STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timing of staged PCI. Five sites will be selected to participate in STAR from a national network of highly experienced CTO-PCI centers across the United States.

Status (registry)
Completed
Study type
Interventional
Enrollment
150 (actual)
First submitted
11 Oct 2021
Start date
23 Nov 2021
Primary completion date
7 Aug 2025
Lead sponsor
Saint Luke's Health System
NCT number
NCT05089864

What you commit to

  • Study type: Interventional
  • Participants enrolled: 150
  • From 23 Nov 2021 to the primary completion date, 7 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously enrolled in STAR.

Other illness

  • Unable to participate in telephone follow-up
    • Too hard of hearing to do follow-up by telephone or deaf.
    • Incarcerated prisoner.
    • History of dementia.
    • Subjects without a way for contact by telephone for follow-up.

Lab values

  • Patient not a candidate for baseline and final angiography (CKD with eGFR\<30).

Other

  • The CTO segment is in a graft.
  • Female subjects with a positive quantitative or qualitative pregnancy test, in accordance with hospital policy.
  • The knuckled guidewire did not cross into the CTO segment during STAR attempt.
  • A stent was placed into the STAR segment during the Index Procedure.
  • Refused participation in the study.
  • Patient enrolled in another study.

Who the study is looking for

  • Subject is scheduled for a PCI procedure for at least one chronic total occlusion with TIMI antegrade flow of zero.
  • Subject is ≥ 18 years of age at the time of consent
  • The operator attempted STAR technique defined as knuckle guidewire across or into the CTO segment during the CTO PCI and is planned for a staged procedure.
  • English speaking due to follow up.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saint Luke's Hospital of Kansas City
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.